Obstetrics and Gynecology

MPR Weekly Dose Podcast #125

A neurostimulation device has been cleared for post-C-section pain; a new plaque psoriasis treatment; the FDA addresses the contrast agent shortage; Lucentis biosimilar treatment is approved; and the recall is expanded for an over-the-counter laxative.